Tetraethylene Glycol

Tetraethylene Glycol

SCHEMBL4609027

CCCCNCCCC.OCCOCCOCCOCCO

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.62
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
THRB P10828 1/20 0.61
HTT P42858 1/20 0.61
MAPT P10636 1/20 0.61
ACHE P22303 5/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPK1 P28482 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
CASP1 P29466 1/20 0.41
SLCO1B3 Q9NPD5 1/20 0.41
SLCO1B1 Q9Y6L6 1/20 0.41
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8257768 0.96 TSHR (0.64) TSHRMEN1KMT2ATHRBHTT
SCHEMBL3861532 0.96 TSHR (0.58) TSHRMEN1KMT2ATHRBHTT
SCHEMBL1052160 0.93 TSHR (0.60) TSHRMEN1KMT2ATHRBHTT
Butoxyethanol SCHEMBL10983791 0.93 TSHR (0.74) TSHRMEN1KMT2ATHRBHTT
Di(Hydroxyethyl)Ether SCHEMBL28030871 0.89 MEN1 (0.65) TSHRMEN1KMT2ATHRBHTT
SCHEMBL11344512 0.88 MEN1 (0.64) TSHRMEN1KMT2ATHRBHTT
SCHEMBL11344130 0.88 MEN1 (0.64) TSHRMEN1KMT2ATHRBHTT
SCHEMBL13538736 0.88 MEN1 (0.64) TSHRMEN1KMT2ATHRBHTT
SCHEMBL11347984 0.88 MEN1 (0.64) TSHRMEN1KMT2ATHRBHTT
SCHEMBL8219819 0.88 MEN1 (0.64) TSHRMEN1KMT2ATHRBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858834-B1 BIOLOGICALLY DEGRADABLE GAS HYDRATE INHIBITORS CLARIANT PRODUKTE DEUTSCHLAND (DE) 2008-10-08 EP disclosed
US-20080177103-A1 Biologically Degradable Gas Hydrate Inhibitors CLARIANT INTERNATIONAL LTD. (CH) 2008-07-24 US disclosed
EP-1858834-A1 BIOLOGICALLY DEGRADABLE GAS HYDRATE INHIBITORS Clariant Produkte (Deutschland) GmbH (DE) 2007-11-28 EP disclosed
WO-2006092208-A1 BIOLOGICALLY DEGRADABLE GAS HYDRATE INHIBITORS CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080177103-A1 Biologically Degradable Gas Hydrate Inhibitors NR1H4, NR1I2, NR1I3 TSHR 603/4885MEN1 2632/4885KMT2A 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.